Biblio Discovery — Demo Discovery Service

10 results for "P. Collins"

Showing 1–10 · 0.78 seconds · RSS

  1. Journal Article Full text

    Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial

    Jan Biegus; Adriaan A. Voors; Sean P. Collins et al.

    European Heart Journal · 2022 · English · OpenAlex Scopus

    AIMS: Effective and safe decongestion remains a major goal for optimal management of patients with acute heart failure (AHF). The effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on decongestion-related endpoints in the EMPULSE trial (NCT0415775) were evaluated. METHODS AND…

  2. Journal Article

    Empagliflozin in Heart Failure

    Matthew Dallas Griffin; Veena S. Rao; Juan Betuel Ivey-Miranda et al.

    Circulation · 2020 · English · OpenAlex Scopus

    BACKGROUND: Sodium-glucose cotransporter-2 inhibitors improve heart failure-related outcomes. The mechanisms underlying these benefits are not well understood, but diuretic properties may contribute. Traditional diuretics such as furosemide induce substantial neurohormonal activation, contributing…

  3. Journal Article Full text

    The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

    Adriaan A. Voors; Christiane E. Angermann; John R. Teerlink et al.

    Nature Medicine · 2022 · English · OpenAlex Scopus

    The sodium-glucose cotransporter 2 inhibitor empagliflozin reduces the risk of cardiovascular death or heart failure hospitalization in patients with chronic heart failure, but whether empagliflozin also improves clinical outcomes when initiated in patients who are hospitalized for acute heart…

  4. Journal Article Full text

    Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock – A Position Statement from the Heart Failure Association of the European Society of Cardiology

    Ovidiu Chioncel; John Parissis; Alexandre Mebazaa et al.

    European Journal of Heart Failure · 2020 · English · OpenAlex Scopus

    Cardiogenic shock (CS) is a complex multifactorial clinical syndrome with extremely high mortality, developing as a continuum, and progressing from the initial insult (underlying cause) to the subsequent occurrence of organ failure and death. There is a large spectrum of CS presentations resulting…

  5. Journal Article Full text

    Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19

    Wesley H. Self; Matthew W. Semler; Lindsay M. Leither et al.

    JAMA · 2020 · English · OpenAlex

    Importance: Data on the efficacy of hydroxychloroquine for the treatment of coronavirus disease 2019 (COVID-19) are needed. Objective: To determine whether hydroxychloroquine is an efficacious treatment for adults hospitalized with COVID-19. Design, Setting, and Participants: This was a…

  6. Journal Article Full text

    COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

    Livio Pagano; Jon Salmanton‐García; Francesco Marchesi et al.

    Journal of Hematology & Oncology · 2021 · English · OpenAlex Scopus

    BACKGROUND: Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse outcomes may improve clinical management in these patients. We therefore studied baseline characteristics of HM…

  7. Journal Article Full text

    Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

    Leora R. Feldstein; Erica Billig Rose; Steven M. Horwitz et al.

    New England Journal of Medicine · 2020 · English · OpenAlex Scopus

    BACKGROUND: Understanding the epidemiology and clinical course of multisystem inflammatory syndrome in children (MIS-C) and its temporal association with coronavirus disease 2019 (Covid-19) is important, given the clinical and public health implications of the syndrome. METHODS: We conducted…

  8. Journal Article Full text

    Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020

    Anita Patel; Daniel B. Jernigan; 2019-nCoV CDC Response Team et al.

    MMWR Morbidity and Mortality Weekly Report · 2020 · English · OpenAlex Scopus

    Also on January 31, the president of the United States signed a "Proclamation on Suspension of Entry as Immigrants and Nonimmigrants of Persons who Pose a Risk of Transmitting 2019 Novel Coronavirus," which limits entry into the United States of persons who traveled to mainland China to U.S…